Wantai Biological announces launch of HPV 9-valent vaccine Cecolin 9 in Thailand

On November 2, according to Wantai Biological, recently, the nine-valent HPV vaccine Cecolin9, jointly developed by Wantai Biological's subsidiary Xiamen Innovax Biotech Co., Ltd. and Xiamen University, was officially launched in Thailand. Data shows that Cecolin9 was approved for marketing in China in 2025 and obtained approval from Thailand's Food and Drug Administration in 2026, making Thailand the first overseas country where it has been approved.